The Early Diagnosis of Alzheimer’s Disease: A Patient-Centred Conversation with the Care Team

Alzheimer’s disease (AD) is a neurodegenerative disorder which accounts for 60–80% of dementia cases, affecting approximately 10 million people in Europe. Neuroimaging techniques and cerebrospinal fluid biomarkers used in combination with cognitive assessment tools open the door to early diagnosis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasreddine, Ziad, Garibotto, Valentina, Kyaga, Simon, Padovani, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837364/
https://www.ncbi.nlm.nih.gov/pubmed/36528836
http://dx.doi.org/10.1007/s40120-022-00428-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837364/
https://www.ncbi.nlm.nih.gov/pubmed/36528836
http://dx.doi.org/10.1007/s40120-022-00428-7

Ejemplares similares